MEXILETINE (Namuscla®)

Clinical Indication

Symptomatic treatment of myotonia in adult patients with non-dystrophic myotonic disorders


In line with NICE TA748 this product should be used by specialist centres only. At the time of classification LLR is not a site of a specialist centre.

Date of classification

January 2020

Do not prescribe

Drugs not recommended for use in LLR because of lack of evidence of clinical effectiveness, cost prioritization or concerns over safety